This inventor holds 1 USPTO granted patent. Top assignee: Somalogic, Incorporated. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Chad Greef: Innovator in Nucleic Acid Ligand Detection
Introduction
Chad Greef is a notable inventor based in Louisville, Colorado. He has made significant contributions to the field of molecular biology, particularly in the detection of protein targets using nucleic acid ligands. His innovative work has led to the development of methods that enhance the accuracy and efficiency of protein detection.
Latest Patents
Chad Greef holds a patent for "Methods and reagents for detecting target binding by nucleic acid ligands." This invention provides novel methods and reagents for detecting the binding of protein targets to nucleic acid ligands. The use of Universal Protein Stains (UPS) allows for the labeling of proteins bound by nucleic acid ligands with a detectable moiety. The methods are particularly useful for detecting protein targets bound to multiplexed arrays of nucleic acid ligands. Additionally, the invention includes methods for the multiplexed evaluation of photocrosslinking nucleic acid ligands, enabling simultaneous assessment of performance and specificity for each ligand.
Career Highlights
Chad Greef is associated with Somalogic, Incorporated, where he applies his expertise in molecular biology and innovation. His work at Somalogic focuses on advancing diagnostic and prognostic medical assays through the use of his patented technologies.
Collaborations
Chad has collaborated with notable colleagues, including Larry M Gold and Jonathan Drew Smith. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Chad Greef's contributions to the detection of protein targets through nucleic acid ligands represent a significant advancement in molecular biology. His innovative methods and patented technologies have the potential to enhance diagnostic capabilities in medical applications.